Dermatology Practices in European Union 2026: Industry Statistics & Trends

The dermatology practices industry in the European Union comprises medical professionals and clinics specializing in the prevention, diagnosis, and treatment of skin, hair, and nail disorders. The industry is moving toward greater integration of digital health tools, multi-disciplinary clinical networks, and advanced light-based therapies to manage chronic conditions and oncological screenings. According to official population-level data from the European Academy of Dermatology and Venereology (EADV) published in 2022, approximately 43.35% of surveyed European adults reported having at least one dermatological disease or condition within the preceding 12 months, highlighting substantial, ste

Industry snapshot

Key public data points

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Dermatology Practices in European Union industry cover?

This industry consists of independent specialist practices, outpatient clinical networks, and dedicated medical centers that provide specialized care for dermatological conditions. The clinical spectrum covers over 3,000 distinct skin pathologies, ranging from acute inflammatory responses to chronic auto-immune diseases and cutaneous oncology.

• •Primary medical services encompass acne treatment, psoriasis management, atopic dermatitis therapies, and systemic screening for malignant melanomas.
• •Aesthetic and cosmetic dermatology procedures, such as laser scar reduction and photo-rejuvenation, are increasingly integrated into private practice portfolios.
• •Clinical operations are categorized under NACE Rev. 2 classification within Division 86 (Human health activities), specifically under medical practice activities.

Who operates in the industry and how is it structured?

The structural composition of the European Union healthcare sector features a blend of public health service providers, private-practice dermatologists, and corporate outpatient networks. While single-practitioner offices have traditionally anchored local care delivery, private equity investments and institutional corporate structures are driving consolidation in major member states like Germany and France.

• •Eurostat structural business statistics for the broader market activities in human health (Division 86) recorded 2.1 million active enterprises across the EU in 2022.
• •The EADV Burden of Skin Diseases survey highlighted that the dermatologist was the second most frequently visited specialist among all medical fields in Europe.
• •According to Eurostat 2022 data, Germany represents the largest individual market participant, accounting for 44.2% of the EU's total value added in market-driven human health activities.

What drives demand in the industry?

Demand for specialized dermatology services is propelled by structural demographic shifts, high disease prevalence, and heightened public awareness regarding skin cancer. The aging European demographic naturally creates an expanded patient base requiring frequent interventions for age-related skin disorders and oncological screenings.

• •An EADV population-level dataset released in 2022 revealed that extrapolated survey figures translate to approximately 185 million individuals affected by skin conditions across Europe.
• •Skin cancer screening and nevus check-ups represent the single most common reason for consulting a dermatologist, accounting for 20.2% of visits according to public survey data.
• •Environmental shifts, including prolonged UV exposure and urban pollution, are driving a steady rise in chronic conditions like rosacea and eczema.

Who are the notable companies in the industry?

The competitive environment features a mix of multinational healthcare providers, specialized private medical groups, and medical technology vendors supporting local practices. Consolidation has led to the emergence of international networks that standardized care delivery, purchasing power, and compliance procedures across European borders.

• •Fresenius SE & Co. KGaA operates extensive medical care centers (MVZs) across Europe, which frequently integrate specialized outpatient dermatology units.
• •Orpea SA (now operating under its restructured corporate identity as emea) manages regional health clinics and care networks providing specialized medical support.
• •Sanofi SA influences the practice landscape by developing advanced biologic treatments, such as Dupixent, which alter clinical treatment paths within practices.
• •Galderma Group AG, a prominent dermatological entity listed publicly on the SIX Swiss Exchange, directly impacts practices through its prescription treatments and aesthetic products.

What are the recent trends and outlook?

The modern practice landscape is defined by the rapid adoption of digital dermatology platforms, remote teledermatology consultations, and artificial intelligence-assisted diagnostic imaging. These innovations allow practitioners to optimize triage pathways and alleviate long patient waiting times across public insurance networks.

• •Teledermatology applications have seen widespread regulatory integration following health system adaptations initiated across the EU.
• •The transition toward precision medicine has increased clinical reliance on targeted biologics for severe psoriasis and atopic dermatitis.
• •Cross-border medical initiatives, such as the European Reference Network for Rare Skin Diseases (ERN Skin), facilitate synchronized data sharing and guidelines.

How is the industry regulated?

Dermatology practices within the European Union must operate under a strict framework governing medical qualifications, pharmaceutical prescribing rules, and medical device usage. Cross-border directives ensure harmonized standards for patient data protection and clinical technology safety across all EU member states.

• •Patient data handling, high-resolution diagnostic imaging, and teleconsultation records are strictly regulated under the General Data Protection Regulation (GDPR).
• •Dermatological hardware, including ablative lasers and dermatoscope devices, must adhere strictly to the European Medical Device Regulation (MDR).
• •Clinical practices are subject to national healthcare provisions and professional oversight from bodies aligned with the European Union of Medical Specialists (UEMS) Section of Dermatology-Venereology.

Government, statistical and trade sources used for this Claight analysis.

• Eurostat Structural Business Statistics 2022 ·
• European Academy of Dermatology and Venereology (EADV) Burden of Skin Diseases Project Report 2022 ·
• European Union of Medical Specialists (UEMS) Section of Dermatology-Venereology Guidelines